mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.002 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.002 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.003 |
mRNA |
SGC0946 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.003 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.003 |